Initiating stiripentol in infants with Dravet syndrome is safe and beneficial, significantly reducing long-lasting seizures including status epilepticus, hospitalizations, and mortality in the critical first years of life.
No takes yet. Share an insight, caveat, or question.
Chiron et al. (2023) studied this question.